Jan Joseph Melenhorst

Associate Professor, Department of Pathology and Laboratory Medicine, University of Pennsylvania

Previously responsible for the product/process development of Kymriah, the world’s first CAR-T cell therapy approved by FDA

Early inventor and pioneer in CAR-T cell therapy

In-depth experience in immunology and immunotherapy, approaches to improving the anti-tumor efficacy of gene-engineered T cells for the treatment of cancers

Over 10 years of working experience in the National Institutes of Health (NIH)